Disciplines:
  • Nursing
  • Advanced Practice Nursing
Hours: 3 Contact Hours
Author(s): Suzanne Mahon, RN, DNSc, AOCN, AGN-BC
Peer Reviewer(s): Ellen Carr, RN, MSN, AOCN
Item#: N1938
Contents: 1 Course Book (38 pages)
Choose the best WS365 Online Nursing Membership for you:
Basic Membership – Access to 1-15 hour courses
PREMIUM Membership – Access to ALL nursing course

A Women's Genetic Risk for Developing Cancer



Reg. Price $21.95
Sale $18.95
Item # N1938
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Release Date: October 16, 2017

Expiration Date: August 31, 2020

Some families have multiple individuals with a history of malignancy, suggesting a hereditary risk beyond what would be expected by chance. Advances in genetic science and testing have made it possible to identify families at risk for developing malignancies because of mutated, absent, or defective genes.

When genetic testing identifies a pathogenic mutation in a family, there is a possibility that family members who do not have a diagnosis of cancer can have genetic testing to clarify whether they have a high risk for developing malignancy. For those family members with a mutation, tailored recommendations can decrease the morbidity and mortality associated with certain cancers in these families. This course provides nurses with key information on how family history can contribute to cancer risk for some cancer diagnoses in women.

 

This course is an extract of, and should not be taken in conjunction with, N1755 - Cancer in Women, 3rd Edition.

Course Objectives

  • Identify the genetic basis of hereditary risk and its key indicators.
  • Identify the components of a pedigree and how the pedigree is utilized to assess an individual’s hereditary risk for cancer.
  • Describe what occurs during a genetic testing session with a credentialed genetics professional.
  • Describe possible outcomes of genetic testing and the implications of testing results for the individual and family members.

Suzanne Mahon, RN, DNSc, AOCN, AGN-BC, has more than 35 years of oncology experience focusing primarily on cancer prevention, early detection, and genetics. She has authored more than 200 publications in peer-reviewed journals. Dr. Mahon is a frequent speaker for both the public and healthcare professionals on cancer-related topics.

 

Ellen Carr, RN, MSN, AOCN, is the Clinical Educator for the Multispecialty Clinic at the Moores Cancer Center (University of California, San Diego). She has been a healthcare writer for more than 30 years, specializing in clinical nursing, therapeutic and diagnostic technologies, and patient advocacy. As of July 2017, she is Editor of the Clinical Journal of Oncology Nursing, a peer-reviewed journal published by the Oncology Nursing Society (ONS).

Carr is a graduate of the University of Colorado, Boulder (BS in Journalism) and the MGH Institute of Health Professions, Boston, MA (MSN in Oncology Nursing). She holds advanced oncology nursing certification from the Oncology Nursing Certification Corporation and is a local and national member of the ONS.

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.